Skip to content
Peptigraph home

IGF-1 LR3 for Weight Loss: What the Evidence Shows

What human and animal studies show about IGF-1 LR3 for weight loss, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureIGF-1 analogUpdated
Strongest evidence
None graded
no study with an outcome for weight loss (PubMed search, 11 Oct 2026)
Human studies
None found
with an outcome for weight loss, in our evidence file (PubMed search, 11 Oct 2026)
Animal studies
None found
with an outcome for weight loss, in our evidence file (PubMed search, 11 Oct 2026)

Evidence for weight loss

None of the study abstracts we summarised for IGF-1 LR3 reported an outcome for weight loss (PubMed search, 11 Oct 2026). Claims that it helps with weight loss are unproven.

How strong is it?

Strongest evidence:No graded study for weight loss (PubMed search, 11 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Weight and body fat as the goal

MedlinePlus says healthy eating patterns and regular physical activity can help you lose weight and lower your chance of weight-related conditions.[6]

What exists for IGF-1 LR3 and fat

The evidence file for IGF-1 LR3 holds 0 human trials of the peptide.

Calculated from human trials 0. Formula: Count of human trials of IGF-1 LR3 in web/src/data/evidence/igf-1-lr3.json; no arithmetic.

In tumour-bearing rats, LR3-IGF-I decreased carcass fat by 30% while insulin increased it almost 2-fold.[7]

In male 5XFAD Alzheimer's-model mice, intranasal LR3-IGF-1 improved body composition but did not significantly alter cognitive symptoms.[8]

In pigs, an LR3-IGF-I infusion decreased average daily gain and food intake.[9]

Limits of the animal data

In normal fetal sheep, LR3 infusion increased body weight but lowered insulin concentrations.[10]

A clinical review of self-administered GH-axis peptides notes there is no regulatory approval for physique- or performance-related indications, and that product composition and dose are uncertain in unregulated supply chains.[11]

Other peptides people research for weight loss

All peptides for weight loss, compared

Common questions

Does IGF-1 LR3 help with weight loss?

None of the studies we summarised for IGF-1 LR3 (PubMed search, 11 Oct 2026) measured an outcome for weight loss. Treat claims that it helps with weight loss as unproven.

Is IGF-1 LR3 approved for weight loss?

No. IGF-1 LR3 is not FDA approved for any use, including weight loss.

What is the best peptide for weight loss?

There is no single answer. Our weight loss overview compares each candidate by evidence grade and legal status rather than by popularity.

Does IGF-1 LR3 burn fat?

Only animal data are cited: a rat study saw carcass fat fall by 30%, and a mouse study noted improved body composition. No human trial is cited.[7]

Is IGF-1 LR3 good for weight loss?

No study cited shows weight loss in people. In pigs, it lowered food intake and daily gain.[9]

More on IGF-1 LR3

Sources

  1. 1PubMed search: ("Long R3"[tiab] OR (LR3[tiab] AND (IGF[tiab] OR "IGF-1"[tiab] OR "IGF-I"[tiab] OR "insulin-like growth factor"[tiab]))) (109 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: ("Long R3 IGF-I"[tiab] OR "LR3 IGF-I"[tiab] OR "IGF-I LR3"[tiab] OR "LR3-IGF-I"[tiab] OR "IGF-1 LR3"[tiab] OR "LR3 IGF-1"[tiab] OR "[Long R3]IGF-I"[tiab]) AND (rat[tiab] OR rats[tiab] OR mice[tiab] OR infusion[tiab] OR muscle[tiab] OR pigs[tiab] OR in vivo[tiab]) (38 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: "long R3 IGF"[tiab] OR "long-R3 IGF"[tiab] OR "LR3-IGF"[tiab] OR "LR3 IGF"[tiab] OR "R3 IGF-I"[tiab] (95 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  4. 4PubMed search: ("LR3"[tiab] AND IGF[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab] OR clearance[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: ("Long R3"[tiab] OR "IGF-1 LR3"[tiab] OR "LR3 IGF"[tiab] OR "LR3-IGF"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  6. 6Official web pageOfficial web page · web page
  7. 7Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.The Biochemical journal · 1994PMID 8053901Accessed 2 Oct 2026
  8. 8Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.Journal of Alzheimer's disease : JAD · 2025PMID 39610283Accessed 2 Oct 2026
  9. 9Long [R3] insulin-like growth factor-I reduces growth, plasma growth hormone, IGF binding protein-3 and endogenous IGF-I concentrations in pigs.The Journal of endocrinology · 1997PMID 9488001Accessed 2 Oct 2026
  10. 10IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.American journal of physiology. Endocrinology and metabolism · 2025PMID 39679943Accessed 2 Oct 2026
  11. 11The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Frontiers in endocrinology · 2026PMID 42395176Accessed 2 Oct 2026

Found an error? Report a correction.